304 related articles for article (PubMed ID: 7970709)
81. Tumorigenic transformation of rat FR3T3 fibroblasts carrying an activated myc oncogene requires subsequent mutational events.
Mougneau E; Cerni C; Tillier F; Cuzin F
Oncogene Res; 1988; 2(2):177-88. PubMed ID: 3217111
[TBL] [Abstract][Full Text] [Related]
82. The functions of oncogene products.
Hunter T
Prog Clin Biol Res; 1989; 288():25-34. PubMed ID: 2541449
[No Abstract] [Full Text] [Related]
83. Transformation of a mammary epithelial cell line by the v-raf and v-mos oncogenes.
Scully JL; Edwards PA
Int J Cancer; 1991 Apr; 48(1):128-35. PubMed ID: 1826898
[TBL] [Abstract][Full Text] [Related]
84. NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors: effect on inositol lipid turnover.
Ruggiero M; Srivastava SK; Fleming TP; Ron D; Eva A
Oncogene; 1989 Jun; 4(6):767-71. PubMed ID: 2543945
[TBL] [Abstract][Full Text] [Related]
85. [Integration of DNA oscillatory vector pSV neo to genome of NIH3T3: importance in investigations of transformation with c-Ha-ras oncogene].
Burzyński A; Wiśniewski R; Wojciechowski W; Porwit-Bóbr Z
Med Dosw Mikrobiol; 1994; 46(1-2):35-41. PubMed ID: 7967925
[TBL] [Abstract][Full Text] [Related]
86. The role of cAMP in regulating tumour cell growth.
Gottesman MM; Fleischmann RD
Cancer Surv; 1986; 5(2):291-308. PubMed ID: 3022924
[TBL] [Abstract][Full Text] [Related]
87. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raf/v-myc-transduced rat liver epithelial cell lines.
Kalimi GH; Hampton LL; Trosko JE; Thorgeirsson SS; Huggett AC
Mol Carcinog; 1992; 5(4):301-10. PubMed ID: 1379816
[TBL] [Abstract][Full Text] [Related]
88. Tyrosine kinases in control of cell growth and transformation.
Mäkelä TP; Alitalo K
Med Biol; 1986; 64(6):325-30. PubMed ID: 3029519
[TBL] [Abstract][Full Text] [Related]
89. An immortalized cell line expresses properties of activated microglial cells.
Bocchini V; Mazzolla R; Barluzzi R; Blasi E; Sick P; Kettenmann H
J Neurosci Res; 1992 Apr; 31(4):616-21. PubMed ID: 1578513
[TBL] [Abstract][Full Text] [Related]
90. Transformation by raf and myc oncogenes.
Rapp UR; Cleveland JL; Storm SM; Beck TW; Huleihel M
Princess Takamatsu Symp; 1986; 17():55-74. PubMed ID: 3332021
[TBL] [Abstract][Full Text] [Related]
91. Reversible transformation by v-sis: a model cell line for analysis of transformation by antisense methods.
Carpenter PM; Mercola M; Mercola D
Antisense Res Dev; 1991; 1(3):289-95. PubMed ID: 1821651
[TBL] [Abstract][Full Text] [Related]
92. Analysis of AP-1 function in cellular transformation pathways.
Suzuki T; Murakami M; Onai N; Fukuda E; Hashimoto Y; Sonobe MH; Kameda T; Ichinose M; Miki K; Iba H
J Virol; 1994 Jun; 68(6):3527-35. PubMed ID: 8189491
[TBL] [Abstract][Full Text] [Related]
93. A dominant negative Raf-1 mutant prevents v-Src-induced transformation.
Qureshi SA; Joseph CK; Hendrickson M; Song J; Gupta R; Bruder J; Rapp U; Foster DA
Biochem Biophys Res Commun; 1993 Apr; 192(2):969-75. PubMed ID: 7683468
[TBL] [Abstract][Full Text] [Related]
94. [Genetic transformation of somatic cells. X. Morphological transformation and changes in the growth characteristics of NIH 3T3 cells administered the oncogene v-myc].
Pospelova TV; Kapitskaia MZ; Dvorianchikov GA; Tomilin NV
Tsitologiia; 1986 Dec; 28(12):1329-35. PubMed ID: 3824523
[TBL] [Abstract][Full Text] [Related]
95. Suppression of dexamethasone-induced metallothionein expression and cis-diamminedichloroplatinum(II) resistance by v-mos.
Basu A; Lazo JS
Cancer Res; 1991 Feb; 51(3):893-6. PubMed ID: 1824827
[TBL] [Abstract][Full Text] [Related]
96. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species.
Joseph P; Muchnok TK; Klishis ML; Roberts JR; Antonini JM; Whong WZ; Ong T
Toxicol Sci; 2001 Jun; 61(2):295-303. PubMed ID: 11353138
[TBL] [Abstract][Full Text] [Related]
97. Defining the mechanisms of transformation through analysis of revertant cells.
Bassin RH; Benade LE
Immunol Ser; 1990; 51():15-47. PubMed ID: 2095917
[No Abstract] [Full Text] [Related]
98. Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells.
Grover-Bardwick A; Adamson E; Mercola D
Carcinogenesis; 1994 Aug; 15(8):1667-74. PubMed ID: 8055649
[TBL] [Abstract][Full Text] [Related]
99. Oncogene.
Das UN
J Assoc Physicians India; 1992 Apr; 40(4):258-61. PubMed ID: 1280637
[TBL] [Abstract][Full Text] [Related]
100. Heterogeneity in transformation efficiency of NIH 3T3 cells as determined by transfection with oncogenes.
Katz E
Eur J Cell Biol; 1986 Dec; 42(2):231-5. PubMed ID: 3816817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
